Home › Burkitt Lymphoma › Michigan › Warren
Burkitt Lymphoma clinical trials in Warren, MI
3 studies for Burkitt Lymphoma are looking for participants at sites in and around Warren (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
RecruitingPhase 2
- Henry Ford Health Warren Hospital, Warren
- Henry Ford Warren Hospital - GLCMS, Warren
- Henry Ford Saint John Hospital - Academic, Grosse Pointe Woods · 6 mi away
- and 1 more
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- Corewell Health Children's, Royal Oak · 7 mi away
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RecruitingPhase 3
- Corewell Health Children's, Royal Oak · 7 mi away
Burkitt Lymphoma trials in other cities
- Houston, TX21 studies
- Milwaukee, WI16 studies
- Philadelphia, PA16 studies
- New York City, NY14 studies
- Chicago, IL14 studies
- Cincinnati, OH12 studies
- Atlanta, GA12 studies
- Seattle, WA11 studies
- Durham, NC10 studies
- Boston, MA10 studies
- Kansas City, MO10 studies
- Aurora, CO10 studies
Other studies in Warren
- Breast Cancer9 studies
- Prostate Cancer7 studies
- Lung Cancer6 studies
- Colorectal Cancer5 studies
- Coronary Artery Disease5 studies
- Non-Small Cell Lung Cancer4 studies
- Aortic Valve Stenosis4 studies
- Ovarian Cancer4 studies
- Multiple Myeloma4 studies
- Bladder Cancer4 studies
- Sjogren's Syndrome3 studies
- Post-COVID Conditions (Long COVID)3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.